KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
Pacific Avenue Capital Partners to acquire LKQ’s $410m Pick Your Part unit
Pacific Avenue Capital Partners to acquire LKQ’s $410m Pick Your Part unit Pacific Avenue Capital...
Morgan Stanley Capital Partners completes Clarity Software Solutions sale after six-year hold
Morgan Stanley Capital Partners completes Clarity Software Solutions sale after six-year hold...
Eldridge targets $1bn for new GP-solutions fund amid private equity liquidity crunch
Eldridge targets $1bn for new GP-solutions fund amid private equity liquidity crunch Eldridge...